KLRC2 and neoplasm: Furthermore, reduced expression of NKG2C, NKG2D, CD161, KIR2DL2/L3/S3, and KIR2DL1/S1 on CD56DimNK cells likely reflects the exhaustion of NK cells in tumor specimens.